The Efficacy and Safety of a Cap-Dependent Endonuclease Inhibitor, TG-1000, in Adolescent and Adult Outpatients with Acute Uncomplicated Influenza: A Multicenter, Randomized, Placebo-Controlled Phase III TrialFang Jin, Nanshan Zhong, Chongyang Duan et al.|SSRN Electronic Journal|2024Cited by 2